NYSE$AMWL
American Well Corp · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Announced financial results, showing revenue growth and improved adjusted EBITDA.
Amwell reported an 11% increase in total revenue to $69.2 million for Q3 2022, driven by subscription revenue growth of 19%. The company's gross margin was 40%. Net loss was ($70.6) million. Adjusted EBITDA improved to ($41.9) million. The company refines its guidance as follows: revenue in the lower end of previously provided range of $275 and $285 million and a new Adjusted EBITDA range of between ($180) million and ($190) million.
- Total revenue reached $69.2 million, an 11% increase compared to Q3 2021.
- Subscription revenue grew by 19% to $31.9 million.
- Gross margin was reported at 40%.
- Total active providers increased by 23% to 98,500.
Headline financials
Revenue & EPS history
American Well · Revenue · Quarterly
$69.2M
Revenue by segment
American Well · $31.9M total across 1 segment · Q3 2022
- Subscription Revenue$31.9M+19.5%100.0%
Forward guidance
The Company believes revenues will be within its original guidance range, set at the first of the year, and is refining its guidance as follows: revenue in the lower end of previously provided range of $275 and $285 million; AMG visits between 1.4 and 1.5 million and a new Adjusted EBITDA range of between ($180) million and ($190) million.
Tailwinds
- Clear visibility to achieving revenue in the lower end of previously provided range of $275 and $285 million
- AMG visits between 1.4 and 1.5 million
- Adjusted EBITDA range of between ($180) million and ($190) million, $10 million better than the prior range of ($190) million and ($200) million
- Excellent feedback on Converge™ platform
- Made great progress with customer migrations this quarter
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+1.4%
Avg return
Earnings day
+2.1%
Avg return
5 days after
-2.2%
Avg return
30 days after
41%
9 / 22 earnings
Positive
+33.8%
Q2 2024
Best reaction
-20.9%
Q1 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | +27.2% | +34.0% | |
| Q4 2025 | +24.7% | +34.9% | +29.8% | |
| Q3 2025 | -9.5% | -20.0% | -20.6% | |
| Q1 2025 | +19.7% | +9.5% | +8.9% | |
| Q4 2024 | -5.0% | -3.6% | -35.5% | |
| Q3 2024 | -5.0% | -5.4% | -0.7% | |
| Q2 2024 | +33.8% | +13.9% | -1.1% | |
| Q1 2024 | +2.0% | +11.4% | -16.3% | |
| Q4 2023 | +23.6% | +20.8% | -16.0% | |
| Q3 2023 | +14.5% | +4.3% | +11.1% | |
| Q2 2023 | -8.3% | -13.9% | -35.2% | |
| Q1 2023 | -3.9% | -2.9% | +17.9% | |
| Q4 2022 | -13.1% | -19.2% | -37.3% | |
| Q3 2022 | -2.2% | +14.9% | -8.3% | |
| Q2 2022 | +9.2% | +6.8% | -4.8% | |
| Q1 2022 | -10.8% | +8.8% | +37.6% | |
| Q4 2021 | +7.2% | +1.0% | -8.0% | |
| Q3 2021 | -7.4% | -3.7% | -29.7% | |
| Q2 2021 | +0.7% | -1.7% | +0.8% | |
| Q1 2021 | -20.9% | -5.7% | +9.5% | |
| Q4 2020 | -4.1% | -10.8% | -1.5% | |
| Q3 2020 | -11.9% | -19.8% | +17.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro